Miao Liu, Liu Yan-Li
Department of Cardiology, Liuzhou People's Hospital, Affiliated of Guangxi Medical University, 545006 Liuzhou, Guangxi, China.
Rev Cardiovasc Med. 2023 Oct 7;24(10):276. doi: 10.31083/j.rcm2410276. eCollection 2023 Oct.
Cardiovascular disease is one of the major diseases threatening the health of Chinese residents, and the death rate has long been the highest on the disease spectrum in China. With the progress of population aging, the prevalence and mortality of cardiovascular diseases remain on the rise, and the current treatment effect on and prognosis of heart failure (HF) are not satisfactory. It is particularly important to explore the potential pathogenic mechanisms of HF and identify new therapeutic targets.
心血管疾病是威胁中国居民健康的主要疾病之一，其死亡率长期以来在中国疾病谱中位居首位。随着人口老龄化进程的推进，心血管疾病的患病率和死亡率持续上升，目前针对心力衰竭（HF）的治疗效果和预后并不理想。探索HF的潜在致病机制并确定新的治疗靶点尤为重要。
